Our growth has been based on a solid foundation of providing products which are both of high quality and cost-effective.
Whatever market changes, regulatory updates or medical advances lie ahead, HBS Healthcare plans to be at the forefront of the industry, making new breakthroughs. We are aiming to have set up our own regulatory affairs department with QPs for total control of the manufacturing and marketing of generics by June 2016.
The pharmacy side of the business has succeeded in becoming the single largest independent pharmacy group in the UK. It is our vision for HBS Healthcare to be in the top twenty generic manufacturers in the UK by 2016. However, the quality of our products and the standard of our customer service will always remain our benchmark.